What the company does
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
What the weekly tape is saying
000220 closed the latest completed week at 3,960 KRW. The 4-week return is -0.5% and the 12-week return is -8.2%. Trend Signal is inactive, Market Dynamics is -1.21. Setup signature: Risk-first tape with a 26/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 4,284 KRW
- Vs Trend Line
- -7.6%
- Fair Value
- 4,486 KRW
- Vs Fair Value
- -11.7%
- 52W High
- 4,972 KRW
- 52W Low
- 3,580 KRW
- Drawdown
- -20.3%
- Range Position
- 27.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 11
- 52W Active Breadth
- 21.2%
- Sector Scope
- KR Healthcare
- Sector Rank
- 8 of 63
- Sector Percentile
- 88.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 3 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 2 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.21
- 4W MD Change
- -43.5%
- Relative Strength
- -51.05
- 4W RS Change
- 0.0%
- Expectation
- Undecided
- Probability
- 52.64%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 955.0K
- 13W Average
- 1.3M
- 52W Average
- 675.8K
- Vs 13W
- 0.7x
- Vs 52W
- 1.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.7%
- 52W Volatility
- 2.5%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 2.0% / -2.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 61.8B
Opportunity signals
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3,960 KRW | 3.7% | 4,284 KRW | 4,486 KRW | -1.21 | -51.05 | 955.0K | Off |
| 5 Jun 2026 | 3,820 KRW | -4.4% | 4,289 KRW | 4,492 KRW | -1.17 | -53.92 | 1.3M | Off |
| 29 May 2026 | 3,995 KRW | 0.6% | 4,296 KRW | 4,501 KRW | -1.03 | -54.60 | 11.5M | Off |
| 22 May 2026 | 3,970 KRW | -0.3% | 4,298 KRW | 4,508 KRW | -0.99 | -52.33 | 310.4K | Off |
| 15 May 2026 | 3,980 KRW | -3.9% | 4,301 KRW | 4,518 KRW | -0.84 | -51.05 | 382.8K | Off |
| 8 May 2026 | 4,140 KRW | -2.5% | 4,308 KRW | 4,529 KRW | -0.76 | -50.13 | 299.3K | Off |
| 1 May 2026 | 4,245 KRW | -2.0% | 4,310 KRW | 4,539 KRW | -0.80 | -43.06 | 162.6K | Off |
| 24 Apr 2026 | 4,330 KRW | -0.6% | 4,310 KRW | 4,548 KRW | -0.88 | -41.95 | 199.8K | Off |
| 17 Apr 2026 | 4,355 KRW | 3.3% | 4,304 KRW | 4,557 KRW | -0.87 | -40.06 | 240.6K | Off |
| 10 Apr 2026 | 4,215 KRW | 2.3% | 4,300 KRW | 4,566 KRW | -0.83 | -39.80 | 241.1K | Off |
| 3 Apr 2026 | 4,120 KRW | -5.3% | 4,301 KRW | 4,578 KRW | -0.62 | -36.97 | 331.0K | Off |
| 27 Mar 2026 | 4,350 KRW | 0.8% | 4,304 KRW | 4,589 KRW | -0.37 | -35.20 | 375.3K | On |
| 20 Mar 2026 | 4,315 KRW | -1.0% | 4,301 KRW | 4,597 KRW | 0.09 | -40.31 | 269.8K | On |
| 13 Mar 2026 | 4,360 KRW | 0.7% | 4,298 KRW | 4,605 KRW | 0.50 | -37.32 | 294.8K | On |